1. Market Overview of Nuclear Medicine and Radiopharmaceutic
1.1 Nuclear Medicine and Radiopharmaceutic Market Overview
1.1.1 Nuclear Medicine and Radiopharmaceutic Product Scope
1.1.2 Market Status and Outlook
1.2 Nuclear Medicine and Radiopharmaceutic Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Nuclear Medicine and Radiopharmaceutic Historic Market Size by Regions (2015-2020)
1.4 Nuclear Medicine and Radiopharmaceutic Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Nuclear Medicine and Radiopharmaceutic Sales Market by Type (2015-2026)
2.1 Global Nuclear Medicine and Radiopharmaceutic Historic Market Size by Type (2015-2020)
2.2 Global Nuclear Medicine and Radiopharmaceutic Forecasted Market Size by Type (2021-2026)
2.3 Diagnostic Radioisotopes
2.4 Therapeutic Radioisotopes
3. Covid-19 Impact Nuclear Medicine and Radiopharmaceutic Sales Market by Application (2015-2026)
3.1 Global Nuclear Medicine and Radiopharmaceutic Historic Market Size by Application (2015-2020)
3.2 Global Nuclear Medicine and Radiopharmaceutic Forecasted Market Size by Application (2021-2026)
3.3 Oncology
3.4 Cardiology
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Nuclear Medicine and Radiopharmaceutic Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Nuclear Medicine and Radiopharmaceutic Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Nuclear Medicine and Radiopharmaceutic Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Nuclear Medicine and Radiopharmaceutic Business
5.1 Company
5.1.1 Company Company Profile
5.1.2 Company Nuclear Medicine and Radiopharmaceutic Product Specification
5.1.3 Company Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Bracco Imaging
5.2.1 Bracco Imaging Company Profile
5.2.2 Bracco Imaging Nuclear Medicine and Radiopharmaceutic Product Specification
5.2.3 Bracco Imaging Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Bayer
5.3.1 Bayer Company Profile
5.3.2 Bayer Nuclear Medicine and Radiopharmaceutic Product Specification
5.3.3 Bayer Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Mallinckrodt
5.4.1 Mallinckrodt Company Profile
5.4.2 Mallinckrodt Nuclear Medicine and Radiopharmaceutic Product Specification
5.4.3 Mallinckrodt Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Nordion
5.5.1 Nordion Company Profile
5.5.2 Nordion Nuclear Medicine and Radiopharmaceutic Product Specification
5.5.3 Nordion Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Triad Isotopes
5.6.1 Triad Isotopes Company Profile
5.6.2 Triad Isotopes Nuclear Medicine and Radiopharmaceutic Product Specification
5.6.3 Triad Isotopes Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Lantheus
5.7.1 Lantheus Company Profile
5.7.2 Lantheus Nuclear Medicine and Radiopharmaceutic Product Specification
5.7.3 Lantheus Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 IBA Group
5.8.1 IBA Group Company Profile
5.8.2 IBA Group Nuclear Medicine and Radiopharmaceutic Product Specification
5.8.3 IBA Group Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 GE Healthcare
5.9.1 GE Healthcare Company Profile
5.9.2 GE Healthcare Nuclear Medicine and Radiopharmaceutic Product Specification
5.9.3 GE Healthcare Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 China Isotope & Radiation
5.10.1 China Isotope & Radiation Company Profile
5.10.2 China Isotope & Radiation Nuclear Medicine and Radiopharmaceutic Product Specification
5.10.3 China Isotope & Radiation Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Jubilant Pharma
5.11.1 Jubilant Pharma Company Profile
5.11.2 Jubilant Pharma Nuclear Medicine and Radiopharmaceutic Product Specification
5.11.3 Jubilant Pharma Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Eli Lilly
5.12.1 Eli Lilly Company Profile
5.12.2 Eli Lilly Nuclear Medicine and Radiopharmaceutic Product Specification
5.12.3 Eli Lilly Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Advanced Accelerator Applications
5.13.1 Advanced Accelerator Applications Company Profile
5.13.2 Advanced Accelerator Applications Nuclear Medicine and Radiopharmaceutic Product Specification
5.13.3 Advanced Accelerator Applications Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 SIEMENS
5.14.1 SIEMENS Company Profile
5.14.2 SIEMENS Nuclear Medicine and Radiopharmaceutic Product Specification
5.14.3 SIEMENS Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Dongcheng
5.15.1 Dongcheng Company Profile
5.15.2 Dongcheng Nuclear Medicine and Radiopharmaceutic Product Specification
5.15.3 Dongcheng Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Navidea
5.16.1 Navidea Company Profile
5.16.2 Navidea Nuclear Medicine and Radiopharmaceutic Product Specification
5.16.3 Navidea Nuclear Medicine and Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
6.2 North America Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
6.3 North America Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
6.4 North America Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
7.2 East Asia Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
7.3 East Asia Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
7.4 East Asia Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
8. Europe
8.1 Europe Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
8.2 Europe Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
8.3 Europe Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
8.4 Europe Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
9.2 South Asia Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
9.3 South Asia Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
9.4 South Asia Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
10.2 Southeast Asia Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
10.3 Southeast Asia Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
10.4 Southeast Asia Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
11.2 Middle East Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
11.3 Middle East Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
11.4 Middle East Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
12. Africa
12.1 Africa Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
12.2 Africa Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
12.3 Africa Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
12.4 Africa Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
13.2 Oceania Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
13.3 Oceania Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
13.4 Oceania Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
14. South America
14.1 South America Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
14.2 South America Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
14.3 South America Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
14.4 South America Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Nuclear Medicine and Radiopharmaceutic Market Size (2015-2026)
15.2 Rest of the World Nuclear Medicine and Radiopharmaceutic Key Players in North America (2015-2020)
15.3 Rest of the World Nuclear Medicine and Radiopharmaceutic Market Size by Type (2015-2020)
15.4 Rest of the World Nuclear Medicine and Radiopharmaceutic Market Size by Application (2015-2020)
16 Nuclear Medicine and Radiopharmaceutic Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.